These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9760678)

  • 21. Structure-activity studies of endothelin leading to novel peptide ETA antagonists.
    Hunt JT; Lee VG; McMullen D; Liu EC; Bolgar M; Delaney CL; Festin SM; Floyd DM; Hedberg A; Natarajan S
    Bioorg Med Chem; 1993 Jul; 1(1):59-65. PubMed ID: 8081838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.
    Raval P; Bingham S; Aiyar N; Elliott JD; Hunter AJ; Ohlstein EH; Parsons AA
    Br J Pharmacol; 1999 Jan; 126(2):485-93. PubMed ID: 10077242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary hemodynamics in newborn piglets during hypoxemia and reoxygenation: blocking of the endothelin-1 receptors.
    Medbø S; Tølløfsrud PA; Saugstad OD
    Pediatr Res; 1999 Nov; 46(5):514-22. PubMed ID: 10541312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of magnetic resonance imaging for evaluation of the efficacy of SB 217242 in neointimal formation.
    Chandra S; Sarkar S; Elliot JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S317-9. PubMed ID: 9595469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).
    Liu G; Henry KJ; Szczepankiewicz BG; Winn M; Kozmina NS; Boyd SA; Wasicak J; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Nguyen B; Marsh KC; Opgenorth TJ
    J Med Chem; 1998 Aug; 41(17):3261-75. PubMed ID: 9703472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670.
    Brooks DP; Contino LC
    Eur J Pharmacol; 1995 Dec; 294(2-3):571-6. PubMed ID: 8750720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel receptor antagonists welcome a new era in endothelin biology.
    Douglas SA; Meek TD; Ohlstein EH
    Trends Pharmacol Sci; 1994 Sep; 15(9):313-6. PubMed ID: 7992380
    [No Abstract]   [Full Text] [Related]  

  • 28. Comment on "Interactions between endothelin-1 and the renin-angiotensin-aldosterone system".
    Gardiner SM; Bennett T
    Cardiovasc Res; 1999 Nov; 44(2):449-51. PubMed ID: 10690321
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of the endothelin receptor antagonist, SB 209670 on cyclosporine-induced nephrotoxicity.
    Ishikawa A; Suzuki K; Fujita K
    Transplant Proc; 1998 Feb; 30(1):40-2. PubMed ID: 9474951
    [No Abstract]   [Full Text] [Related]  

  • 30. Endothelin antagonists and hypertension: a question of dose?
    Goddard J; Webb DJ
    Hypertension; 2002 Sep; 40(3):e1-2; author reply e1-2. PubMed ID: 12215481
    [No Abstract]   [Full Text] [Related]  

  • 31. 1,3-Disubstituted-2-carboxy quinolones: highly potent and selective endothelin A receptor antagonists.
    Haesslein JL; Baholet I; Fortin M; Iltis A; Khider J; Periers AM; Pierre C; Vevert JP
    Bioorg Med Chem Lett; 2000 Jul; 10(13):1487-90. PubMed ID: 10888339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin receptor antagonists: structures, synthesis, selectivity and therapeutic applications.
    Boss C; Bolli M; Weller T
    Curr Med Chem; 2002 Feb; 9(3):349-83. PubMed ID: 11860362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.
    Hay DW; Luttmann MA
    J Pharmacol Exp Ther; 1997 Feb; 280(2):959-65. PubMed ID: 9023312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigations of structural requirements for endothelin antagonism.
    van der Walle CF; Barlow DJ
    Curr Med Chem; 1998 Aug; 5(4):321-35. PubMed ID: 9668198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin receptor antagonists: status and learning 20 years on.
    Palmer MJ
    Prog Med Chem; 2009; 47():203-37. PubMed ID: 19328292
    [No Abstract]   [Full Text] [Related]  

  • 38. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
    Cody WL; He JX; DePue PL; Waite LA; Leonard DM; Sefler AM; Kaltenbronn JS; Haleen SJ; Walker DM; Flynn MA
    J Med Chem; 1995 Jul; 38(15):2809-19. PubMed ID: 7636842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endothelin receptor blockers--one more agent for the treatment of pulmonary hypertension].
    Minushkina LO; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2003; 43(9):67-71. PubMed ID: 14593372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, syntheses, and structure-activity relationships of indan derivatives as endothelin antagonists; new lead generation of non-peptidic antagonist from peptidic leads.
    Morimoto H; Fukushima C; Yamauchi R; Hosino T; Kikkawa K; Yasuda K; Yamada K
    Bioorg Med Chem; 2001 Feb; 9(2):255-68. PubMed ID: 11249118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.